KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Neogenomics (NEO) over the last 15 years, with Q4 2025 value amounting to $435.0 million.

  • Neogenomics' Total Non-Current Liabilities rose 11.74% to $435.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $435.0 million, marking a year-over-year increase of 11.74%. This contributed to the annual value of $435.0 million for FY2025, which is 11.74% up from last year.
  • According to the latest figures from Q4 2025, Neogenomics' Total Non-Current Liabilities is $435.0 million, which was up 11.74% from $438.6 million recorded in Q3 2025.
  • Neogenomics' Total Non-Current Liabilities' 5-year high stood at $676.4 million during Q3 2021, with a 5-year trough of $433.5 million in Q1 2025.
  • For the 5-year period, Neogenomics' Total Non-Current Liabilities averaged around $575.0 million, with its median value being $641.8 million (2023).
  • Per our database at Business Quant, Neogenomics' Total Non-Current Liabilities skyrocketed by 26535.93% in 2021 and then plummeted by 3247.34% in 2024.
  • Quarter analysis of 5 years shows Neogenomics' Total Non-Current Liabilities stood at $674.3 million in 2021, then decreased by 3.29% to $652.1 million in 2022, then fell by 1.33% to $643.4 million in 2023, then plummeted by 32.47% to $434.5 million in 2024, then grew by 0.12% to $435.0 million in 2025.
  • Its Total Non-Current Liabilities was $435.0 million in Q4 2025, compared to $438.6 million in Q3 2025 and $439.8 million in Q2 2025.